Try our Advanced Search for more refined results

August 31, 2021

Eagle Pharmaceuticals, Inc. v. Slayback Pharma LLC et al

View recent docket activity

Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.

Coverage

  1. October 26, 2022

    Apotex, Slayback Beat Lymphoma Drug Patent Suit In Del.

    A Delaware federal judge cleared pharmaceutical companies Apotex and Slayback of patent infringement claims lodged by the maker of cancer drug Belrapzo over their new drug applications, ruling that the disputed products don't meet the "ready to use" limitation in the patent.

1 other articles on this case. View all »

Parties

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Direct access to case information and documents.
  • All significant new filings across U.S. federal district courts, updated hourly on business days.
  • Full-text searches on all patent complaints in federal courts.
  • No-fee downloads of the complaints and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

View the parties now

Already a subscriber? Click here to login